Cargando…

Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma

PURPOSE: Comparative data on the impact of imaging on management is lacking for multiple myeloma. This study compared the diagnostic performance and impact on management of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) and whole-body magnetic resonance imag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westerland, Olwen, Amlani, Ashik, Kelly-Morland, Christian, Fraczek, Michal, Bailey, Katherine, Gleeson, Mary, El-Najjar, Inas, Streetly, Matthew, Bassett, Paul, Cook, Gary J. R., Goh, Vicky
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241666/ https://www.ncbi.nlm.nih.gov/pubmed/33469686 http://dx.doi.org/10.1007/s00259-020-05182-2

Ejemplares similares

Correlation between whole skeleton dual energy CT calcium-subtracted attenuation and bone marrow infiltration in multiple myeloma
por: Gu, Renyang, et al.
Publicado: (2022)

National survey of imaging practice for suspected or confirmed plasma cell malignancies
por: Westerland, Olwen Amy, et al.
Publicado: (2018)

Integrated slice-specific dynamic shimming for whole-body diffusion-weighted MR imaging at 1.5 T
por: McElroy, Sarah, et al.
Publicado: (2020)

Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated (18)F–Fluorodeoxyglucose ((18)F–FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study
por: Kelly-Morland, Christian, et al.
Publicado: (2017)

The effects of segmentation algorithms on the measurement of (18)F-FDG PET texture parameters in non-small cell lung cancer
por: Bashir, Usman, et al.
Publicado: (2017)

Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT
por: O’Shea, Robert J., et al.
Publicado: (2022)

Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of (18)F-FDG PET
por: Cook, Gary J. R., et al.
Publicado: (2017)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma
por: Prezzi, Davide, et al.
Publicado: (2023)

PET/CT F18-FDG with soft tissue plasmacytomas in multiple myeloma
por: Martí, Alejandro, et al.
Publicado: (2021)

Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI
por: Sharkey, Amy R., et al.
Publicado: (2021)

Pulmonary Mycobacterium kansasii Infection Mimicking Malignancy on the (18)F-FDG PET Scan in a Patient Receiving Etanercept: A Case Report and Literature Review
por: Min, Zaw, et al.
Publicado: (2014)

Quantitative techniques in (18)FDG PET scanning in oncology
por: Castell, F, et al.
Publicado: (2008)

The effect of post-injection (18)F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1
por: Lovat, Eitan, et al.
Publicado: (2017)

Everolimus-induced pulmonary toxicity: Findings on (18)F-FDG PET/CT imaging
por: Dejust, Sebastien, et al.
Publicado: (2018)

Polymicrobial Pyomyositis in a Patient with Suspected Myeloma on (18)F-FDG PET-CT
por: Kalra, Simran, et al.
Publicado: (2022)

Does Measurement of First-Order and Heterogeneity Parameters Improve Response Assessment of Bone Metastases in Breast Cancer Compared to SUV(max) in [(18)F]fluoride and [(18)F]FDG PET?
por: Azad, Gurdip K., et al.
Publicado: (2018)

Comparison of [(18)F]fluciclovine and [(18)F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
por: Stokke, Caroline, et al.
Publicado: (2022)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

Measurement of (18)F-FDG PET tumor heterogeneity improves early assessment of response to bevacizumab compared with the standard size and uptake metrics in a colorectal cancer model
por: Bashir, Usman, et al.
Publicado: (2019)

Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
por: Connor, Steve, et al.
Publicado: (2021)

(18)F-FDG PET/CT in Primary AL Hepatic Amyloidosis Associated with Multiple Myeloma
por: Son, Youn Mi, et al.
Publicado: (2011)

Case of non‐secretory multiple myeloma eventually diagnosed by (18)F‐FDG PET/CT
por: Haratake, Daisuke, et al.
Publicado: (2022)

Added value of regional (18)F-FDG PET/MRI-assisted whole-body (18)F-FDG PET/CT in malignant ascites with unknown primary origin
por: Fu, Yiru, et al.
Publicado: (2023)

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience
por: Elboga, Umut, et al.
Publicado: (2022)

18-FDG PET in lung transplantation
por: Algieri, I, et al.
Publicado: (2015)

Myocarditis on (18)FDG-PET imaging
por: Chaaban, Nourhan, et al.
Publicado: (2022)

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast (18)F-FDG PET/MRI compared to (18)F-FDG PET/CT and CT
por: Kirchner, Julian, et al.
Publicado: (2017)

Quantitative, Dynamic (18)F-FDG PET/CT in Monitoring of Smoldering Myeloma: A Case Report
por: Sachpekidis, Christos, et al.
Publicado: (2021)

An Incidental Renal Oncocytoma: (18)F-Choline PET/MRI
por: Mallia, Andrew, et al.
Publicado: (2016)

A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET/CT, 18F-NaF-PET/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients
por: Dyrberg, Eva, et al.
Publicado: (2017)

Diagnostic performance of integrated whole-body (18)F-FDG PET/MRI for detecting bone marrow involvement in indolent lymphoma: Comparison with (18)F-FDG PET or MRI alone
por: Chen, Xuetao, et al.
Publicado: (2023)

Whole-Body (18)FDG-PET in an Arthritis Paraneoplastic Syndrome Revealed an Underlying Hematological Neoplasm
por: Cammilleri, Serge, et al.
Publicado: (2013)

PET probes beyond (18)F-FDG
por: Jiang, Lei, et al.
Publicado: (2014)

Feasibility of (18)FDG PET in the cardiac inflammation
por: Osiecki, Sebastian, et al.
Publicado: (2020)

(11)C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to (18)F-FDG PET/CT and Prognostic Value
por: Morales-Lozano, Maria I., et al.
Publicado: (2022)

(18)FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
por: Lapa, Constantin, et al.
Publicado: (2014)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

([18F])FDG Positron emission tomography with whole body magnetic resonance imaging (([18F])FDG-PET/MRI) as a diagnosis tool in Schwannomatosis
por: Gallais Sérézal, I., et al.
Publicado: (2021)

Detection of Extramedullary Multiple Myeloma in Liver by FDG-PET/CT
por: Kim, Dae-Weung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_73ti3k921bfl5pa20og30tgb5o